Thor Medical ASA

Thor Medical ASA

0.39
EUR
0.00
(0.00%)
-0.39EPS
30.40MMarket Cap
Mar 03Next Earn

Total Valuation

EUR

As of June 30, 2022, Thor Medical ASA carries a market capitalization of 30.40M, placing it among publicly traded companies globally. Its enterprise value stands at 2.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap30.40M
Enterprise Value2.53M

Important Dates

Thor Medical ASA's next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of June 30, 2022, Thor Medical ASA has 119.10M shares outstanding.

Shares Outstanding119.10M

Valuation Ratios

These figures are as of June 30, 2022.

PB Ratio1.72
P/TBV Ratio1.72
P/FCF Ratio-0.72
P/OCF Ratio-0.72

Financial Position

As of June 30, 2022, Thor Medical ASA maintains a current ratio of 2.50, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is - -, indicating a certain level of leverage, while an interest coverage ratio of -1,369.64 demonstrates limited ability to service its debt obligations.

Current Ratio2.50
Quick Ratio2.32
Interest Coverage-1,369.64

Financial Efficiency

Over the twelve months ended June 30, 2022, Thor Medical ASA posted a negative return on equity (ROE) of -155.90, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -107.68, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 39.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-155.90
Return on Assets (ROA)-107.68
Employee Count39.00

Taxes

EUR

Over the twelve months ended June 30, 2022, Thor Medical ASA recorded 111,994.38 in income tax expense. The company reported a pretax loss of -41.98M and -42.10M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax111,994.38

Stock Price Statistics

EUR

As of the close on November 17, 2026, Thor Medical ASA's stock has gained approximately 28.01% over the past 52 weeks. The 50-day moving average sits at 0.41, while the 200-day moving average is 0.43.

52-Week Price Change28.01%
50-Day Moving Average0.41
200-Day Moving Average0.43

Income Statement

EUR

Over the twelve months ended June 30, 2022, Thor Medical ASA generated - - in revenue and converted that into -42.10M in net income, yielding earnings per share of -0.39. EBITDA reached -41.70M, while operating income came in at -42.71M.

Operating Income-42.71M
Pretax Income-41.98M
Net Income-42.10M
EBITDA-41.70M
EBIT-42.71M
Earnings Per Share (EPS)-0.39

Balance Sheet

EUR

As of June 30, 2022, Thor Medical ASA holds 27.87M in cash and equivalents against - - in total debt, resulting in a net debt position of -27.87M. Total book value stands at 17.70M, with working capital of 18.02M providing operational flexibility.

Cash & Cash Equivalents27.87M
Net Debt-27.87M
Equity (Book Value)17.70M
Book Value Per Share0.15
Working Capital18.02M

Cash Flow

EUR

Thor Medical ASA produced -38.17M in operating cash flow over the twelve months ended June 30, 2022. After subtracting -14,544.72 in capital expenditures, free cash flow totaled -38.18M - equivalent to -0.35 per share.

Operating Cash Flow-38.17M
Capital Expenditures-14,544.72
Free Cash Flow-38.18M
FCF Per Share-0.35

Dividends & Yields

These figures cover the twelve months ended June 30, 2022. Free cash flow yield is negative at -138.03: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -71.28, meaning Thor Medical ASA raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-71.28
FCF Yield-138.03

Stock Splits

Thor Medical ASA's most recent stock split took place on June 19, 2025.

Last Split Date6/19/2025

Scores

As of June 30, 2022, Thor Medical ASA has an Altman Z-Score of -2.74, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-2.74